Syndax Pharmaceuticals (SNDX) PT Lowered to $37 at UBS
Tweet
Share
E-mailGet Alerts SNDX Hot Sheet
Price: $19.32 --0%
Rating Summary:
18 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 11 | New: 23
Rating Summary:
18 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 11 | New: 23
Join SI Premium – FREE
UBS analyst David Dai lowered the price target on Syndax Pharmaceuticals (NASDAQ: SNDX) to $37.00 (from $38.00) while maintaining a Buy rating.
You May Also Be Interested In
- Wingstop (WING) PT Lowered to $225 at RBC Capital
- Chipbond Technology Corp. (6147:TT) PT Raised to NT$225 at JPMorgan
- Sun Hung Kai Properties (16:HK) (SUHJY) PT Lowered to HK$140 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
